Enzolytics Inc. (ENZC)

• 24.5 million [21.6 million–25.5 million] people were accessing antiretroviral therapy (end ofJune 2019).
  37.9 million [32.7 million–44.0 million] people globally were living with HIV (end 2018).
  1.7 million [1.4 million–2.3 million] people became newly infected with HIV (end 2018).
  770 000 [570 000–1.1 million] people died from AIDS-related illnesses (end 2018).
  74.9 million [58.3 million–98.1 million] people have become infected with HIV since the start of the epidemic (end 2018).
  32.0 million [23.6 million–43.8 million] people have died from AIDS-related illnesses since the start of the epidemic (end 2018).

People living with HIV

• In 2018, there were 37.9 million [32.7 million–44.0 million] people living with HIV.
  • 36.2 million [31.3 million–42.0 million] adults.
    1.7 million [1.3 million–2.2 million] children (<15 years).
  
  79% [67–92%] of all people living with HIV knew their HIV status.
  About 8.1 million people did not know that they were living with HIV.

People living with HIV accessing antiretroviral therapy

• As of end of June 2019, 24.5 million [21.6 million–25.5 million] people were accessingantiretroviral therapy.
  In 2018, 23.3 million [20.5 million–24.3 million] people living with HIV were accessing antiretroviral therapy, up from 7.7 million [6.8 million–8.0 million] in 2010.
  In 2018, 62% [47–74%] of all people living with HIV were accessing treatment.
  • 62% [47–75%] of adults aged 15 years and older living with HIV had access to treatment, as did 54% [37–73%] of children aged 0–14 years.
    68% [52-82%] of female adults aged 15 years and older had access to treatment however, just 55% [41-68%] of male adults aged 15 years and older had access.
  
  82% [62– >95%] of pregnant women living with HIV had access to antiretroviral medicines to prevent transmission of HIV to their child in 2018.

New HIV infections

• New HIV infections have been reduced by 40% since the peak in 1997.
  • In 2018, around 1.7 million [1.4 million–2.3 million] were newly infected with HIV, compared to 2.9 million [2.3 million–3.8 million] in 1997.
  
  Since 2010, new HIV infections have declined by an estimated 16%, from 2.1 million [1.6 million–2.7 million] to 1.7 million [1.4 million–2.3 million] in 2018.
  • Since 2010, new HIV infections among children have declined by 41%, from 280 000 [190 000–430 000] in 2010 to 160 000 [110 000–260 000] in 2018.

AIDS-related deaths

• AIDS-related deaths have been reduced by more than 56% since the peak in 2004.
  • In 2018, around 770 000 [570 000–1.1 million] people died from AIDS-related illnesses worldwide, compared to 1.7 million [1.3 million–2.4 million] in 2004 and 1.2 million [860 000–1.6 million] in 2010.
  
  AIDS-related mortality has declined by 33% since 2010.

90–90–90

• In 2018, 79% [67–92%] of people living with HIV knew their status.
  Among people who knew their status, 78% [69–82%] were accessing treatment.
  And among people accessing treatment, 86% [72–92%] were virally suppressed.
  Of all people living with HIV, 79% [67-92%] knew their status, 62% [47-74%] were accessing treatment and 53% [43-63%] were virally suppressed in 2018.

Women

• Every week, around 6000 young women aged 15–24 years become infected with HIV.
  • In sub-Saharan Africa, four in five new infections among adolescents aged 15–19 years are in girls. Young women aged 15–24 years are twice as likely to be living with HIV than men.
  
  More than one third (35%) of women around the world have experienced physical and/or sexual violence at some time in their lives.
  • In some regions, women who have experienced physical or sexual intimate partner violence are 1.5 times more likely to acquire HIV than women who have not experienced such violence.

Key populations

• Key populations and their sexual partners account for:
  • 54% of new HIV infections globally.
    More than 95% of new HIV infections in Eastern Europe and Central Asia.
    95% of new HIV infections in Middle East and North Africa.
    88% of new HIV infections in Western and central Europe and North America.
    78% of new HIV infections in Asia and the Pacific.
    65% of new HIV infections in Latin America.
    64% of new HIV infections in Western and central Africa.
    47% of new HIV infections in the Caribbean.
    25% of new HIV infections in eastern and southern Africa.
  
  The risk of acquiring HIV is:
  • 22 times higher among men who have sex with men.
    22 times higher among people who inject drugs.
    21 times higher for sex workers.
    12 times higher for transgender people.

HIV/tuberculosis (TB)

• TB remains the leading cause of death among people living with HIV, accounting for around one in three AIDS-related deaths.
  In 2017, an estimated 10.0 million [9.0-11.1million] people developed TB disease, approximately 9% were living with HIV.
  • People living with HIV with no TB symptoms need TB preventative therapy, which lessens the risk of developing TB and reduces TB/HIV death rates by around 40%.
  
  It is estimated that 49% of people living with HIV and tuberculosis are unaware of their coinfection and are therefore not receiving care.

Investments

• At the end of 2018, US$ 19.0 billion (constant 2016 dollars) was available for the AIDS response in low- and middle-income countries, almost 1 billion less than in 2017.
  • Around 56% of the total resources for HIV in low- and middle-income countries in 2018 were from domestic sources.
  
  UNAIDS estimates that US$ 26.2 billion (constant 2016 dollars) will be required for the AIDS response in 2020.

Download the full version to view regional statistics, global and regional data

Source: 

https://www.unaids.org/en/resources/fact-sheet

Expanded access to antiretroviral therapy (ART) and a declining incidence of HIV infections have led to a steep fall globally in the number of adults and children dying from HIV-related causes. The estimated 770 000 [570 000−1 100 000] people dying from HIV globally in 2018 were 56% fewer than in 2004 (the peak) and 33% fewer than in 2010 in spite of a period of substantial population growth in many high burden countries.

Nevertheless, there is no room for complacency. Countries need to live up to their commitment to end the AIDS epidemic as a public health threat by 2030 -- a target included in the 2030 Agenda for Sustainable Development adopted by the United Nations General Assembly in September 2015. The immediate challenge is to reach the Fast-Track targets for 2020, as HIV-related deaths are still unacceptably high.

The 2020 targets include reducing the number of people dying from HIV-related causes to fewer than 500 000. Based on current estimates, this provides an opportunity to prevent almost 300 000 deaths per year.

The drop in HIV-related mortality is especially evident in the regions with the greatest burden of HIV infection, including the WHO African Region, home to over 61% of people dying from HIV-related causes in 2018. An estimated 470 000 [340 000−630 000] people died in the African Region from HIV-related causes in 2018, which indicates that mortality has dropped by almost 40% since 2010.

Source: 

https://www.who.int/gho/hiv/epidemic_status/deaths_text/en/